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The aim of our study is to determine whether there is a relationship between familial Mediterranean fever (FMF) attacks and
serum leptin levels. We enrolled 25 patients (22 males and 3 females) and 25 healthy controls (21 males and 4 females) with a
mean age of 24.42 ± 1.22 (Mean ± SEM) years and 24.30 ± 1.19 years (Mean ± SEM), respectively. We investigated serum levels
of leptin, interleukin-6 (IL-6), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), ﬁbrinogen, and leukocyte counts
before the attack and 8–12 hours after the attack started. The same parameters have been investigated in the control subjects. The
mean serum leptin levels before the attacks were 6.45 ± 1.05 (Mean ± SEM) and during the attacks were 7.59 ± 1.3 (Mean ±
SEM) in FMF group, respectively. There was a slight increase in serum leptin levels during the attacks but it was not statistically
signiﬁcant (P>. 05). The mean serum leptin levels were 6.12 ± 2.81 in the control group which were not diﬀerent from the mean
serum leptin levels before and during the attack periods in the study group (P>. 05). However, there were statistical diﬀerences in
theserumlevelsofIL-6,ESR,CRP,ﬁbrinogen,andleukocytecountsbeforeandduringtheattackperiods(P<. 05). No correlation
was found between serum leptin levels and IL-6, ESR, CRP, ﬁbrinogen, and leukocyte counts (P>. 05). Serum leptin levels do not
increase during FMF attacks and therefore it is not useful for diagnostic purposes and follow-up during treatment.
Copyright © 2006 B¨ ulent Toy et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
Familial Mediterranean fever (FMF) has been characterized
by fever and recurrent aseptic inﬂammation of serosal spaces
with a typical familial tendency [1]. A lot of metabolic and
immunologic changes happen to occur in these patients dur-
ing the attack period. Acute phase reactants, such as erythro-
cyte sedimentation rate (ESR), ﬁbrinogen, and C-reactive
protein (CRP) [2, 3], and pro-inﬂammatory cytokines, such
as interleukin-6 (IL-6), have been found to be elevated dur-
ing the attacks [4, 5].
The close relationship between IL-6 and FMF attacks is
without any debate, that serum IL-6 shows meaningful in-
creases during these attacks [1, 5, 6] and colchicum treat-
ment turns IL-6 levels down to normal values [4].
Leptin is secreted from adipocytes, and after interaction
with its receptors, it controls body weight and daily energy
consumption [7, 8]. Increasingly, data show that leptin has
some important role in the regulation of acute phase re-
action [9]. Also it is such an immunoregulatory substance
which belongs to class-1 cytokine family [10]. Indeed, leptin
structurally looks like granulocyte colony stimulating factor
which is a member of IL-6 cytokine family [11]. Adipocytes
secrete leptin [12] and even IL-6 [13] in acute inﬂammatory
conditions. During this acute inﬂammatory response, serum
leptin levels have been shown to increase and possibly con-
tribute to anorexia and cachexia that accompany chronic in-
fections[14].Interestingly,verylowcaloriedietinobesesub-
jects leads to mutual decrease in blood IL-6 and leptin levels
[15]. Moreover, in septic subjects, serum IL-6 and leptin lev-
els correlate very well [14].
In this study, we plan to scrutinize whether or not lep-
tin has any role in triggering and/or regulation of inﬂam-
matory response in FMF attacks. Accordingly, we investi-
gated serum leptin levels before and during acute attacks of
FMF.2 Mediators of Inﬂammation
MATERIALS AND METHODS
The study included 25 patients with FMF diagnosis accord-
ing to Eliakim criteria [16]. The mean age was 24.42 ± 1.22
years (range: 20–52 years), and the gender distribution was
22 males and 3 females. Inclusion criteria were as follows:
FMF attacks should have been started at least 1 year ago; ab-
sence of systemic diseases including chronic renal failure, di-
abetes mellitus, ischemic heart disease, malignancy, trauma,
heavy exercise, and infectious and inﬂammatory disorders;
and lack of any drug use including colchicine with potential
eﬀectsonthebiochemicalandimmunologicparametersdur-
ing the last 4 weeks. The control group included 25 healthy
people with a mean age 24.30 ± 1.19 (range: 21–43 years).
The gender distribution was 21 males and 4 females.
Blood samples were taken before attack and 8–12 hours
after the attack started in FMF cases. We obtained blood
samples from the FMF patients and controls after 12 hours
of fasting since serum IL-6 levels increase has been shown
acutelystimulated bymeals [17]. Moreover, concentration of
circulating leptin is reduced in starvation [18, 19].
The total blood count was measured by STKS autoan-
alyzer (Hialeah, Finland). ESR was measured by Wester-
green method on the same day of obtaining samples, and
ESR within one hour was recorded. The rates of 0–15mm/h
for males and 0–20mm/h for females were considered to
be within normal ranges. CRP (Biosystems SA, Barcelona,
Spain) levels were measured by turbidimetric method after
assessing absorbance at BIS-310 photometer (Berlin, Ger-
many), the levels equal to or below 6mg/L were consid-
ered to be normal levels. Fibrinogen levels were measured
by a photo-optical method using ﬁbrinogen (Sigma Diag-
nostics) reagents in an Amelung AMAX 190 Plus device
(Taufkirchen, Germany), and 200–400mg/dL were consid-
ered to be normal values. Serum IL-6 values were measured
by IMMUNOTECH enzyme immunoassay kit (Westbrook,
Me) (Cat  = 1120, 96 tests), (normal < 8pg/mL).Serumlep-
tin analysis was performed by using Medizym Leptin ELISA
kit (Medipan Diagnostica, GmbH, Selchow, Germany) in all
patients and controls.
STATISTICS
The statistical analysis was made by using SPSS 11.0
(Chicago,Ill)inapersonalcomputer.Groupswerecompared
according to independent sample t test, and the results of
serum leptin levels of presymptomatic and symptomatic pe-
riods were compared by using paired t test. Pearson correla-
tion test was also used to make correlation analysis.
RESULTS
There was no statistical diﬀerence in respect to age distribu-
tion in between the controls and FMF study group. Out of
25 patients, 23 had fever and signs of aseptic peritonitis, 12
had pleural involvement, and 17 cases had joint inﬂamma-
tion. No case had dermatologic ﬁnding and/or amyloidal ac-
cumulation. Thirteen cases had positive family history. Five
had previous history of appendectomy.
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Figure 1: (a) Leptin levels before (Mean ± SEM: 6.4528 ± 1.05
ng/mL) and during (Mean ± SEM: 7.5928 ± 1.3ng/mL) the at-
tacks in FMF patients. Serum leptin levels did not increase signif-
icantly during the attacks (P>. 05). (b) Serum IL-6 levels before
(Mean ± SEM: 70.18 ± 14.8pg/mL) and during (Mean ± SEM:
163.32 ± 25.25pg/mL) attacks. IL-6 levels increased signiﬁcantly
during the attacks (P<. 001).
The mean serum leptin concentration in control group
was between 1.81 and 9.64ng/mL (Mean ± SEM: 4.282 ±
0.385). In FMF group, it was 6.4528 ± 1.05 (range: 0.32–
20.55ng/mL) and 7.5928±1.3( r a n g e :0 .2–20.40ng/mL) be-
fore and during FMF attacks, respectively. The mean serum
leptin levels in the study group before and during the attacks
did not diﬀer signiﬁcantly from that of the control group
(P>. 05). Although serum leptin levels increased to some
extent during the attacks, this was not signiﬁcant statistically
(P>. 05) (Figure 1(a)). However, serum leukocyte counts,
sedimentation rate, and C-reactive protein and IL-6 levels
were found to increase signiﬁcantly during the FMF attacks
(P<. 05) (Figure 1(b), Figure 2,T a b l e1). There was an ap-
parent correlation between the body mass index and serum
leptin levels (r = 0.433, P<. 05) before attacks Figure 3.
W ec o u l dn o tﬁ n dac o r r e l a t i o nb e t w e e ns e r u ml e p t i nl e v e l s
during attacks (r = 0.326, P>. 05). BMI does not correlateB¨ ulent Toy et al 3
Table 1: Laboratory test before and during FMF attacks.
Leukocyte (mm3) Sedimentation (mm/h) CRP (mg/L) Fibrinogen (mg/L)
Before the attacks: Mean ± SEM 7244 ±813.81 17.56 ±2.23 18.28 ± 2.61 399.52 ±16.38
During the attacks: Mean ± SEM 12220 ±785 30.64 ±2.86 26.88 ± 2.94 532.16 ±24.6
P value <. 01 <. 01 <. 01 <. 01
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Figure 2: Correlation plot of leptin before and during FMF attacks together with IL-6 plot. Although serum leptin levels increased to some
extent during the attacks, it was not statistical signiﬁcant (P>. 05). Serum IL-6 levels increased from 70.18 ± 14.8 (Mean ± SEM) to
163.32 ±25.25 (Mean ± SEM) and they were statistically signiﬁcant (P<. 001).
with other parameters. There was no correlation comparing
serum leptin levels with the leukocyte counts, sedimentation
rate, ﬁbrinogen, CRP levels and serum IL-6 (P>. 05). IL-6
did not correlate with ﬁbrinogen (P>. 05) levels.
DISCUSSION
Our aim was to deﬁne the role of leptin and ﬁnd out if there
is any relationship between serum leptin and IL-6 levels in
a typical systemic inﬂammatory condition like FMF. Leptin
has been already accepted as closely connected with the cy-
tokine network. Though, we found that serum leptin lev-
els increase during FMF attacks, this increase was statisti-
cally not signiﬁcant (P>. 05). However, serum leukocyte
counts, ﬁbrinogen, erythrocyte sedimentation rate, and C-
reactive protein levels were shown to increase signiﬁcantly as
expected. Additionally, we could not ﬁnd a correlation be-
tween serum IL-6 and leptin levels.
Acute inﬂammation can lead to elevated mouse serum
leptin levels and interestingly serum leptin levels in mouse
has a trend to increase even more after administration of
IL-6 [20]. Leptin levels are acutely increased by many acute
phase factors, such as TNF, IL-1, and IL-6, and during bacte-
rialinfectionorlipopolysaccharidechallenge[11].Moreover,
leptin itself was shown directly to induce the production of
interleukin-6andotheracutephasereactants[21].Leptindi-
rectly stimulates the production of interleukin-6 [22]. Ad-
ditionally, leptin might stimulate acute phase protein pro-
duction through the IL-6 dependent intracellular signaling
pathway [23]. Moreover, there are some studies showing a
correlation between leptin and IL-6. One of them indicated
that there are clear correlations between the serum levels of
IL-6 and leptin (r = 0.45, P<. 05) TNF-alpha and leptin
(r = 0.49, P<. 05) in patients with intra-abdominal sepsis
during postoperative period [14]. Similarly, in diabetic and
nondiabetic obese persons, there were signiﬁcant correla-
tionsbetweenleptinandIL-6andleptinandBMI(r = 0.841,
P<. 05). After weight loss, serum leptin and IL-6 concentra-
tions decreased signiﬁcantly in the same patient groups [15].
We measured ﬁbrinogen to discriminate the attack and
attack-freeperiodsoftheFMFpatients[5,24].Inthepresent
study, we could not detect any correlation between ﬁbrino-
gen and leptin and ﬁbrinogen and IL-6 (P>. 05).
On this background, it is very logical to consider lep-
tin as a participant in the inﬂammatory process associated
with FMF. However, our study could not indicate statistically
signiﬁcant increase in serum leptin levels during the acute
attack periods. Furthermore, in the present study, serum
leptin levels before FMF attacks were found to correlate
well with the body mass indexes like some studies [25–27].4 Mediators of Inﬂammation
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Figure 3: Correlation graph between BMI and preattack leptin lev-
els in FMF patient (r = 0.433, P<. 05).
However, there were no statistically signiﬁcant correlations
between the body mass indexes and serum leptin levels dur-
ing the attacks. A completely similar ﬁnding has been re-
ported in septic patients in whom no correlation was found
betweenthese2parameters[14].Thismayberelatedtosome
unknown complicated regulatory pathways for serum leptin
levels during FMF attacks. Indeed, the activation of cytokine
network in FMF is not based extensively on IL-6 and the in-
teraction of the cytokine network is rather complex. Simi-
larly, a relevant literature indicates no correlation between
disease activity and serum leptin levels in cases with roma-
toid arthritis [27, 28].
As a conclusion, serum leptin levels do not increase sta-
tistically signiﬁcantly in FMF attacks and therefore it is not
usefulfordiagnosticpurposesand/orfollow-upduringtreat-
ment.
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